Pilose antler (Cervus elaphus Linnaeus) polysaccharide and polypeptide extract inhibits bone resorption in high turnover type osteoporosis by stimulating the MAKP and MMP-9 signaling pathways
- 15 December 2022
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 304, 116052
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 10 references indexed in Scilit:
- Therapeutic Anabolic and Anticatabolic Benefits of Natural Chinese Medicines for the Treatment of OsteoporosisFrontiers in Pharmacology, 2019
- The Nuclear Translocation of Mitogen-Activated Protein Kinases: Molecular Mechanisms and Use as Novel Therapeutic TargetNeuroendocrinology, 2018
- Pilose antler peptide protects osteoblasts from inflammatory and oxidative injury through EGF/EGFR signalingInternational Journal of Biological Macromolecules, 2017
- Selective Regulation of MAPK Signaling Mediates RANKL-dependent Osteoclast DifferentiationInternational Journal of Biological Sciences, 2016
- Cornu Cervi Pantotrichum Supplementation Improves Exercise Performance and Protects against Physical Fatigue in MiceMolecules, 2014
- The anti-osteoporotic effect of velvet antler polypeptides from Cervus elaphus Linnaeus in ovariectomized ratsJournal of Ethnopharmacology, 2013
- Erk1 Positively Regulates Osteoclast Differentiation and Bone Resorptive ActivityPLOS ONE, 2011
- Bisphosphonates for OsteoporosisNew England Journal of Medicine, 2010
- Matrix metalloproteinases and boneBone, 2008
- Erk5 is activated and acts as a survival factor in mitosisCellular Signalling, 2007